July 26, 2011

BioSignia Board Elects Chairman

BioSignia today announced the election of E. B. Chester as Chairman of the Board of Directors of BioSignia. He was elected by unanimous vote of the Directors at its recent quarterly meeting in Raleigh, NC.

Mr. Chester joined the Board of Directors of BioSignia in January of 2011 and has had an immediate impact on the commercialization of BioSignia’s technologies. “I am proud to be the Chairman of the Board of Directors of an organization that is poised to become a market leader in several industries. It’s an honor,” said Chester.

Mr. Chester’s business experience includes ownership and executive management of privately and publically owned businesses in Manufacturing, Cable Television, Outdoor Advertising, Banking, Real Estate Aviation Services and Power sports. Currently he and his family are one of the larger group owners of Harley-Davidson dealerships in the United States.

“E. B. Chester has been a valuable member of our Board of Directors,” said John A. Williams, President and CEO of BioSignia. “His background in finance and sales is a tremendous resource and BioSignia is privileged to have someone with his experience leading our Board.”

Mr. Chester lives in Beaver Creek, Colorado and Paradise Valley, Arizona. He will become an active member of BioSignia’s leadership.

For more information on BioSignia, please call 888.324.6627 or email info@biosignia.com.

***
About BioSignia
Headquartered in Cary, N.C., BioSignia is a leading technology and software company focused on bringing innovative risk assessment modeling solutions to the preventive healthcare and life insurance underwriting markets. BioSignia's patented Technology, Synthesis Analysis, provides the underpinnings of the healthcare application, Know Your Number® (KYN), and life insurance application, Mortality Assessment Technology® (MAT). This modeling capability represents a quantum leap forward in both morbidity and mortality risk assessment. BioSignia's R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for better risk assessment, as well as effective chronic disease prevention, management, and treatment. For more information about BioSignia, visit: www.biosignia.com.

BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627
© Copyright 2015 BioSignia, All Rights Reserved